Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem-cell therapy for amyotrophic lateral sclerosis.

Vincenzo Silani1, Lidia Cova, Massimo Corbo

  • 1Department of Neurology and Laboratory of Neuroscience, Dino Ferrari Centre, University of Milan Medical School-IRCCS Istituto Auxologico Italiano, Milano, Italy. Silanivincenzo@silani.com

Lancet (London, England)
|July 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis.

Molecular neurodegeneration·2026
Same author

IFRA: A Machine Learning-Based Instrumented Fall Risk Assessment Scale Derived from an Instrumented Timed Up and Go Test in Stroke Patients.

Healthcare (Basel, Switzerland)·2026
Same author

Understanding Long-Term Survival in ALS: A Cohort Study on Subject Characteristics and Prognostic Factors.

Journal of clinical medicine·2025
Same author

A Short Version of Carers' Quality of Life Questionnaire for Parkinsonism: Data from Progressive Supranuclear Palsy Network.

Movement disorders clinical practice·2025
Same author

De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementia.

BMJ case reports·2025
Same author

AGREE: an upper limb motorized exoskeleton for restoring arm functions: a single-blinded randomized controlled trial.

Journal of neuroengineering and rehabilitation·2025

Stem-cell therapy shows promise for amyotrophic lateral sclerosis (ALS) by potentially replacing damaged motor neurons. Further preclinical research is crucial for optimizing this cell-replacement strategy for ALS treatment.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Amyotrophic lateral sclerosis (ALS) lacks effective drug treatments, making stem-cell therapy a promising avenue.
  • Preclinical studies in animal models show potential for stem-cell transplantation to restore function or delay neurodegeneration.
  • Adult stem cells' ability to transdifferentiate offers new possibilities for cell-based therapies in ALS.

Purpose of the Study:

  • To explore the potential of stem-cell transplantation as a therapeutic strategy for amyotrophic lateral sclerosis (ALS).
  • To review preclinical evidence and early clinical safety data for stem-cell therapies in ALS.

Main Methods:

  • Review of preclinical studies on stem-cell transplantation in neurodegenerative disease models.
  • Analysis of findings from Clement et al. (2003) on non-neuronal cell roles in motor neuron degeneration.

Related Experiment Videos

  • Examination of Mazzini et al. (2003) study on autologous bone-marrow-derived stem cells in ALS patients.

    • Main Results:

    • Non-neuronal cells, like wild-type glial cells, can delay motor neuron degeneration in SOD1G93A mice.
    • Autologous bone-marrow-derived stem cell injection into the spinal cord of ALS patients demonstrated clinical safety.
    • Early successes in animal models suggest stem-cell therapy can restore function or delay degeneration.

    Conclusions:

    • Stem-cell therapy is a viable candidate for ALS treatment, supported by preclinical data and transdifferentiation potential.
    • Successful cell-replacement therapy for ALS requires robust preclinical evidence due to the complexity of restoring neuronal connectivity.
    • Future ALS stem-cell therapies may need combination approaches, including drugs, antioxidants, or trophic molecules.